MGRX - MangoRx Future Price to Earnings

Brandmark of MangoRx (MGRX)

Mangoceuticals, Inc. (MGRX) pricing power is based on unique prescription gels, which determines the trajectory of the company's future P/E ratio on the GURU.Markets chart, where the 0.00 level represents the current value. The integration of telemedicine into a private wellness ecosystem expands the brand's influence, while financial stability relies on efficient online order conversion and strict control of marketing expenses.

MGRX - mangorx.com Forward P/E Multiple over the range 04/28/2023 - 11/13/2026

MGRX (MangoRx): analytical breakdowns and indicator data

- stock quotes and analyst forecast:
Stock Price Mangoceuticals, Inc.|MGRX - Broker Consensus Forecast
- market capitalization statistics:
Market Value Mangoceuticals Inc.|MGRX - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Value per Share Mangoceuticals|MGRX - Book Capitalization|Market Value to Book Value Ratio mangorx.com|MGRX - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Mangoceuticals, Inc.|MGRX - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Mangoceuticals, Inc.|MGRX - Company Cumulative Debt|Debts to Book Capitalization Mangoceuticals Inc.|MGRX - Company Long-Term Liabilities|Company Short-Term Debts Mangoceuticals|Quick Liquidity Indicator mangorx.com
- earnings and market ratios statistics:
MGRX - Net Profit|Future Profit Mangoceuticals, Inc.|MGRX - Market Price to Net Income Ratio|Forward P/E Multiple Mangoceuticals, Inc.|MGRX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Mangoceuticals Inc.|MGRX - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Mangoceuticals|MGRX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months mangorx.com|MGRX - Earnings per share growth in current year|Net earnings per share growth forecast for next year Mangoceuticals, Inc.
Analysis of all company metrics:Mangoceuticals
Brand item of Mangoceuticals, Inc.

Mangoceuticals, Inc. (MGRX) holds a strong position in the digital transformation of men's health, leveraging telemedicine to optimize access to therapy. By analyzing the company's forward P/E ratio, an investor assesses the current share price relative to projected earnings for the coming year, which helps determine the extent of the premium paid for future growth. This chart captures the inflection points between market expectations and the actual efficiency of the business model.

Competitors of Mangoceuticals, Inc.

Forward P/E Multiple HIMS|Hinge Health, Inc. - Price to Future Earnings Ratio|Future Price to Earnings Teladoc Inc. TDOC|TALK - Projected Price to Earnings|LifeMD Corp - Forward P/E Multiple|AMWL - Forward P/E Multiple|DarioHealth (DRIO) - Future Price to Earnings|Price to Future Earnings Ratio VSEE|MNDR (MANADR) - Forward P/E Multiple|ACCD - Forward Price to Earnings Multiple|Future Price to Earnings Biotricity, Inc. (BTCY)|LYT - Projected Price to Earnings Ratio|Forward P/E Multiple OTRK (Ontrak)|SHLT - Projected Price to Earnings|Thorne - Forward P/E Multiple